다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Elicio Therapeutics Inc (ELTX)
Elicio Therapeutics Inc (ELTX) 뉴스

ELTX

Elicio Therapeutics (ELTX)

Elicio Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ELTX

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/08	06:30	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/12/19	06:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/12/12	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/12/12	21:00	GlobeNewswire Inc.	Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/12/03	21:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/12/03	21:00	GlobeNewswire Inc.	Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/11/25	21:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/11/25	21:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/11/22	22:06	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/11/22	06:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/11/21	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/11/14	06:21	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/11/14	06:05	GlobeNewswire Inc.	Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/11/08	06:27	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/11/08	06:05	GlobeNewswire Inc.	Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer (“SITC”) 2024 Annual Meeting	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/11/07	23:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/10/31	21:30	GlobeNewswire Inc.	Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/10/17	21:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/10/16	21:30	GlobeNewswire Inc.	Elicio Therapeutics Reports Inducement Grants	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/10/03	05:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/10/03	05:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/10/03	05:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/09/28	05:42	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/09/28	05:41	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/09/18	05:05	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/09/17	21:31	GlobeNewswire Inc.	Elicio Therapeutics Reports Inducement Grants	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/09/13	21:30	GlobeNewswire Inc.	Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile Vaccines	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/08/28	21:00	GlobeNewswire Inc.	Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/08/14	05:30	GlobeNewswire Inc.	Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates	NASDAQ:ELTX	Elicio Therapeutics Inc
2024/08/13	05:05	GlobeNewswire Inc.	Elicio Therapeutics Announces Closing of Private Placement of $20.0 Million Convertible Note	NASDAQ:ELTX	Elicio Therapeutics Inc

검색 관련기사 보기:NASDAQ:ELTX

1 2 3 다음 >>

Deutsche Telekom (QX)

US Dollar vs Sterling

US Dollar vs Yen

BNP Paribas (QX)

Health Care Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관